A Randomized Double-Blind Evaluation of a Novel Biotin and Silicon Ingredient Complex on the Hair and Skin of Healthy Women

D. Kalman, S. Hewlings
{"title":"A Randomized Double-Blind Evaluation of a Novel Biotin and Silicon Ingredient Complex on the Hair and Skin of Healthy Women","authors":"D. Kalman, S. Hewlings","doi":"10.35248/2155-9554.21.12.551","DOIUrl":null,"url":null,"abstract":"Introduction: Age related changes in hair and skin impact quality of life. Interventions to mitigate these changes are of interest. Aim: To examine the safety and efficacy of LustrivaTM (a novel source of biotin and silicon) at a high or lower dose compared to placebo for impacts on hair and skin. Materials and Methods: In a randomized, double-blind study, 90 healthy female subjects with self-reported thinning hair who met Savin/Ludwig Scale criteria I-2 to II-1 by physician evaluation were randomized to one of three groups for 12 weeks (n=30/group): LustrivaTM High-Dose (LHD), LustrivaTM Low-Dose (LLD) or Placebo (PL). Hair quality and thickness measured by the TrichoScan HD testing system and skin parameters (facial wrinkles, fine lines, skin texture, skin color evenness, skin elasticity) measured by the Antera 3DTM System and the CutometerTM Dual MPA 580 system. Results: There was a significant increase in hair thickness measured by change in % vellus hair and % terminal hair and in the ratio of % vellus to terminal hair in LHD compared to PL at Week 3, maintained throughout the study (p=0.029). LHD had a significant decrease in facial wrinkles (12 Weeks) measured by a change in maximal wrinkle depth vs. PL (p=0.031). After 12 weeks compared to baseline LHD significantly improved facial wrinkle Maximum Depth, Indentation Index and Score, facial fine lines Indentation Index and Score, and facial texture Maximum Height, Roughness and Score (p<0.05), no change in PL. There were no changes for skin elasticity between groups. For some hair and skin parameters, LLD showed improvements less than LHD but that approached significance (p<0.1). All groups improved in subjective nail endpoints vs. baseline with no significant differences between groups. No adverse events reported. Conclusion: LHD significantly increased hair thickness and reduced facial wrinkle depth compared to placebo and performed better than the LLD in most parameters. Future studies are warranted.","PeriodicalId":15448,"journal":{"name":"Journal of clinical & experimental dermatology research","volume":"15 1","pages":"1-5"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical & experimental dermatology research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35248/2155-9554.21.12.551","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Age related changes in hair and skin impact quality of life. Interventions to mitigate these changes are of interest. Aim: To examine the safety and efficacy of LustrivaTM (a novel source of biotin and silicon) at a high or lower dose compared to placebo for impacts on hair and skin. Materials and Methods: In a randomized, double-blind study, 90 healthy female subjects with self-reported thinning hair who met Savin/Ludwig Scale criteria I-2 to II-1 by physician evaluation were randomized to one of three groups for 12 weeks (n=30/group): LustrivaTM High-Dose (LHD), LustrivaTM Low-Dose (LLD) or Placebo (PL). Hair quality and thickness measured by the TrichoScan HD testing system and skin parameters (facial wrinkles, fine lines, skin texture, skin color evenness, skin elasticity) measured by the Antera 3DTM System and the CutometerTM Dual MPA 580 system. Results: There was a significant increase in hair thickness measured by change in % vellus hair and % terminal hair and in the ratio of % vellus to terminal hair in LHD compared to PL at Week 3, maintained throughout the study (p=0.029). LHD had a significant decrease in facial wrinkles (12 Weeks) measured by a change in maximal wrinkle depth vs. PL (p=0.031). After 12 weeks compared to baseline LHD significantly improved facial wrinkle Maximum Depth, Indentation Index and Score, facial fine lines Indentation Index and Score, and facial texture Maximum Height, Roughness and Score (p<0.05), no change in PL. There were no changes for skin elasticity between groups. For some hair and skin parameters, LLD showed improvements less than LHD but that approached significance (p<0.1). All groups improved in subjective nail endpoints vs. baseline with no significant differences between groups. No adverse events reported. Conclusion: LHD significantly increased hair thickness and reduced facial wrinkle depth compared to placebo and performed better than the LLD in most parameters. Future studies are warranted.
一种新型生物素硅复合物对健康女性头发和皮肤的随机双盲评价
年龄相关的头发和皮肤变化影响生活质量。缓解这些变化的干预措施值得关注。目的:研究LustrivaTM(一种新型生物素和硅源)在高剂量或低剂量下对头发和皮肤影响的安全性和有效性。材料和方法:在一项随机双盲研究中,90名自我报告头发稀疏的健康女性受试者,经医生评估符合Savin/Ludwig量表标准I-2至II-1,随机分为三组(n=30/组):LustrivaTM高剂量(LHD), LustrivaTM低剂量(LLD)或安慰剂(PL),为期12周。通过TrichoScan高清测试系统测量头发质量和厚度,通过Antera 3DTM系统和CutometerTM Dual MPA 580系统测量皮肤参数(面部皱纹、细纹、皮肤纹理、肤色均匀度、皮肤弹性)。结果:与PL相比,在第3周,通过测量%绒毛和%末端毛的变化以及%绒毛与末端毛的比例,LHD的毛发厚度显着增加,并在整个研究中保持(p=0.029)。与PL相比,LHD的面部皱纹(12周)显著减少,最大皱纹深度的变化(p=0.031)。12周后,与基线相比,LHD显著改善了面部皱纹最大深度、压痕指数和评分,面部细纹压痕指数和评分,面部纹理最大高度、粗糙度和评分(p<0.05), PL无变化。组间皮肤弹性无变化。对于某些毛发和皮肤参数,LLD的改善程度低于LHD,但接近显著性(p<0.1)。与基线相比,所有组的主观指甲终点均有改善,组间无显著差异。无不良事件报告。结论:与安慰剂相比,LHD显著增加了毛发厚度,减少了面部皱纹深度,并在大多数参数上优于LLD。未来的研究是有必要的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信